Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10:155–9.
Article
CAS
PubMed
Google Scholar
Wang KC, Chang HY. Molecular mechanisms of long noncoding RNAs. Mol Cell. 2011;43(6):904–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Derrien T, Johnson R, Bussotti G, Tanzer A, Djebali S, Tilgner H, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–89.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wapinski O, Chang HY. Long noncoding RNAs and human disease. Trends Cell Biol. 2011;21(6):354–61.
Article
CAS
PubMed
Google Scholar
Lee JT, Bartolomei MS. X-inactivation, imprinting and long noncoding RNAs in health and disease. Cell. 2013;152:1308–23.
Article
CAS
PubMed
Google Scholar
Yang Z, Lu Y, Xu Q, Tang B, Park C-K, Chen X. HULC and H19 played different roles in overall and disease-free survival from hepatocellular carcinoma after curative hepatectomy: a preliminary analysis from gene expression omnibus. Di Markers. 2015;2015:191029.
Google Scholar
Scaria V, Pasha A. Long non-coding RNAs in infection biology. Front Genet. 2012;3:308.8.
Google Scholar
Li J, Xuan Z, Liu C. Long non-coding RNAs and complex human diseases. Int J Mol Sci. 2013;14(9):18790–808. https://doi.org/10.3390/ijms140918790.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen X, Yan GY. Novel human lncRNA-disease association inference based onlncRNA expression profiles. Bioinformatics. 2013;29:2617–24.
Article
CAS
PubMed
Google Scholar
Sun J, et al. Inferring novel lncRNA–disease associations based on a random walk model of a lncRNA functional similarity network. Mol BioSyst. 2014;10:2074–81.
Article
CAS
PubMed
Google Scholar
Li J, et al. A bioinformatics method for predicting long noncoding RNAs associated with vascular disease. Sci China Life Sci. 2014;57:852–7.
Article
CAS
PubMed
Google Scholar
Yang X, Gao L, Guo X, et al. A network based method for analysis of lncRNA-disease associations and prediction of lncRNAs implicated in diseases. PLoS One. 2014;9(1):e87797.
Article
PubMed
PubMed Central
Google Scholar
Alaimo S, Giugno R, Pulvirenti A. ncPred: ncRNA-disease association prediction through tripartite network-based inference. Front Bioeng Biotechnol. 2014;2:71.
Article
PubMed
PubMed Central
Google Scholar
Chen X. Predicting lncRNA-disease associations and constructing lncRNA functional similarity network based on the information of miRNA. Sci Rep. 2015;5:13186.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chen G, Wang Z, Wang D, Qiu C, Liu M, Chen X, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. Nucleic Acids Res. 2013;41:D983–6.
Article
CAS
PubMed
Google Scholar
Helwak A, Kudla G, Dudnakova T, Tollervey D. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell. 2013;153(3):654–65.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sören S, Gunnar R, Konrad R, Bottou L, Chapelle O, DeCoste D, Weston J, editors. In: Large-Scale Kernel Machines, chap. 4. Cambridge: MIT Press; 2007. p. 73–104.
Ismail B, Dauda U. Standardization and its effects on k-means clustering algorithm. Res J Appl Sci Eng Technol. 2013;6(17):3299–303.
Google Scholar
Vert JP, Tsuda K, Scholkopf B. A primer on kernel methods. Kernel Methods in Comput Biol. 2004;35–70:7.
Google Scholar
Kondo M, Suzuki H, Ueda R, Osada H, Takagi K, Takahashi T, Takahashi T. Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers. Oncogene. 1995;10(6):1193–8.
CAS
PubMed
Google Scholar
Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncRNA HOTAIR in lung cancer. J Hematol Oncol. 2014;7:90.
Article
PubMed
PubMed Central
Google Scholar
Tano K, Akimitsu N. Long non-coding RNAs in cancer progression. Front Genet. 2012;3:219.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tseng JJ, Hsieh YT, Hsu SL, Chou MM. Metastasis associated lung adenocarcinoma transcript 1 is up-regulated in placenta previa increta/percreta and strongly associated with trophoblast-like cell invasion in vitro. Mol Hum Reprod. 2009;15(11):725–31.
Article
CAS
PubMed
Google Scholar
Yang YR, Zang SZ, Zhong CL, Li YX, Zhao SS, Feng XJ. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer. Int J Clin Exp Pathol. 2014;7(10):6929–35.
CAS
PubMed
PubMed Central
Google Scholar
Tantai J, Hu D, Yang Y, Geng J. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer. Int J Clin Exp Pathol. 2015;8(7):7887–95.
CAS
PubMed
PubMed Central
Google Scholar
Park SL, et al. Pleiotropic associations of risk variants identified for other cancers with lung cancer risk: the PAGE and TRICL consortia. J Natl Cancer Inst. 2014;106(4):dju061.
Article
PubMed
PubMed Central
Google Scholar
Llovet JM, Lok A. Hepatitis B virus genotype and mutants: risk factors for hepatocellular carcinoma. JNCI J Natl Cancer Ins. 2008;100(16):1121–3.
Article
Google Scholar
Qi P, Du X. The long non-coding RNAs, a new cancer diagnostic and therapeutic gold mine. Mod Pathol. 2013;26:155–65.
Article
CAS
PubMed
Google Scholar
Iizuka N, Oka M, Tamesa T, Hamamoto Y, Yamada-Okabe H. Imbalance in expression levels of insulin-like growth factor 2 and H19 transcripts linked to progression of hepatocellular carcinoma. Anticancer Res. 2004;24(6):4085–9.
CAS
PubMed
Google Scholar
Yuan SX, Tao QF, Wang J, Yang F, Liu L, Wang LL, Zhang J, Yang Y, Liu H, Wang F, Sun SH, Zhou WP. Antisense long non-coding RNA PCNA-AS1 promotes tumor growth by regulating proliferating cell nuclear antigen in hepatocellular carcinoma. Cancer Lett. 2014;349(1):87–94.
Article
CAS
PubMed
Google Scholar
Ortiz-Cuaran S, Cox D, Villar S, Friesen MD, Durand G, Chabrier A, Khuhaprema T, Sangrajrang S, Ognjanovic S, Groopman JD, Hainaut P, Le Calvez-Kelm F. Association between TP53 R249S mutation and polymorphisms in TP53 intron 1 in hepatocellular carcinoma. Genes Chromosomes Cancer. 2013;52(10):912–9.
Article
CAS
PubMed
Google Scholar
Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, Hondermarck H, Curgy JJ, Dugimont T, Adriaenssens E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280(33):29625–36.
Article
CAS
PubMed
Google Scholar
Zhang K, Luo Z, Zhang Y, Zhang L, Wu L, Liu L, Yang J, Song X, Liu J. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer. Cancer Biomark. 2016;17(2):187–94.
Article
CAS
PubMed
Google Scholar
Adriaenssens E, Dumont L, Lottin S, Bolle D, Leprêtre A, Delobelle A, Bouali F, Dugimont T, Coll J, Curgy JJ. H19 overexpression in breast adenocarcinoma stromal cells is associated with tumor values and steroid receptor status but independent of p53 and Ki-67 expression. Am J Pathol. 1998;153(5):1597–607.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang Z, Zhu Z, Zhang B, Li W, Li X, Wu X, Wang L, Fu L, Fu L, Dong JT. Frequent mutation of rs13281615 and its association with PVT1 expression and cell proliferation in breast cancer. J Genet Genomics. 2014;41(4):187–95.
Article
CAS
PubMed
Google Scholar
Guan Y, Kuo WL, Stilwell JL, Takano H, Lapuk AV, Fridlyand J, Mao JH, Yu M, Miller MA, Santos JL, Kalloger SE, Carlson JW, Ginzinger DG, Celniker SE, Mills GB, Huntsman DG, Gray JW. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin Cancer Res. 2007;13(19):5745–55.
Article
CAS
PubMed
Google Scholar
Hube F, Guo J, Chooniedass-Kothari S, Cooper C, Hamedani MK, Dibrov AA. Alternative splicing of the first intron of the steroid receptor RNA activator (SRA) participates in the generation of coding and noncoding RNA isoforms in breast cancer cell lines. DNA Cell Biol. 2006;25:418–28.
Article
CAS
PubMed
Google Scholar
Cao HY, Wang S, Zhang ZY, Lou JY. Association between the WRAP53 gene rs2287499 C>G polymorphism and cancer risk:a meta-analysis. Genet Mol Res. 2016;15(3):25.
Google Scholar
Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J. Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J. 2013;280(7):1709–16.
Article
CAS
PubMed
Google Scholar
Mahmoudi S, Henriksson S, Corcoran M, Méndez-Vidal C, Wiman KG, Farnebo M. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage. Mol Cell. 2009;33(4):462–71.
Article
CAS
PubMed
Google Scholar
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J, et al. LncRNA h19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014;281:3766–75.
Article
CAS
PubMed
Google Scholar
Perez DS, Hoage TR, Pritchett JR, Ducharme-Smith AL, Halling ML, Ganapathiraju SC, Streng PS, Smith DI. Long, abundantly expressed non-coding transcripts are altered in cancer. Hum Mol Genet. 2008;17:642–55.
Article
CAS
PubMed
Google Scholar
Fehringer G, et al. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 2016;76(17):5103–14.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang A, Zhao JC, Kim J, Fong KW, Yang YA, Chakravarti D, Mo YY, Yu J. LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep. 2015;13(1):209–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F, Wei M, Shen J, Hou J, Gao X, Xu C, Huang J, Zhao Y, Sun Y. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J Urol. 2013;190(6):2278–87.
Article
CAS
PubMed
Google Scholar
Prensner JR, Chen W, Han S, Iyer MK, Cao Q, Kothari V, Evans JR, Knudsen KE, Paulsen MT, Ljungman M, Lawrence TS, Chinnaiyan AM, Feng FY. The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia. 2014;16(11):900–8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Prensner JR, Iyer MK, Balbin OA, Dhanasekaran SM, Cao Q, Brenner JC, Laxman B, Asangani IA, Grasso CS, Kominsky HD, Cao X, Jing X, Wang X, Siddiqui J, Wei JT, Robinson D, Iyer HK, Palanisamy N, Maher CA, Chinnaiyan AM. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29(8):742–9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kurisu T, Tanaka T, Ishii J, Matsumura K, Sugimura K, Nakatani T, Kawashima H. Expression and function of human steroid receptor RNA activator in prostate cancer cells: role of endogenous hSRA protein in androgen receptor-mediated transcription. Prostate Cancer Prostatic Dis. 2006;9(2):173–8.
Article
CAS
PubMed
Google Scholar
Laner T, Schulz WA, Engers R, Müller M, Florl AR. Hypomethylation of the XIST gene promoter in prostate cancer. Oncol Res. 2005;15(5):257–64.
Article
CAS
PubMed
Google Scholar
Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, Xu TP, Xia R, Yang JS, De W, Jf C. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget. 2014;5(8):2276–92.
PubMed
PubMed Central
Google Scholar
Lee NK, Lee JH, Park CH, Yu D, Lee YC, Cheong JH, Noh SH, Lee SK. Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma. Biochem Biophys Res Commun. 2014;451(2):171–8.
Article
CAS
PubMed
Google Scholar
Wang J, Su L, Chen X, Li P, Cai Q, Yu B, Liu B, Wu W, Zhu Z. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother. 2014;68(5):557–64.
Article
CAS
PubMed
Google Scholar